Connecticut, May 21, 2025 — Connecticut Attorney General William Tong has issued a statewide warning about unauthorized weight-loss drugs being sold both online and at in-person clinics. These products mimic FDA-approved medications like Ozempic and Wegovy but are unregulated, raising serious health concerns.
Tong cautioned that using these counterfeit drugs—known as GLP-1 receptor agonists—can lead to dangerous side effects, including the risk of overdose.
“If you are using these products, stop and see a doctor,” Tong said. “If you’re selling them, stop now—or we will take action.”
The AG’s office has already filed lawsuits against two online retailers, including Florida-based Triggered Brands, which openly markets vials of GLP-1 peptides. Although the company includes a disclaimer stating the drugs are “for research purposes only,” Tong argues this doesn’t absolve them of liability.
Doctors across the state echo these concerns. Dr. Maria Cecilia Asnis of Stamford Hospital warned that unapproved versions of weight-loss medications often contain unregulated additives. Without medical supervision, users are at risk of complications, including infections and respiratory issues.
“These are not cosmetics,” Dr. Asnis said. “They are serious medications that should only be used under professional guidance.”
The warning comes amid rising demand for prescription weight-loss drugs. Social media ads and influencers have further driven interest, especially among younger audiences, fueling a black market for cheaper, imitation versions.
No healthcare providers have been charged yet, but Tong made clear that continued sales of unauthorized drugs could lead to legal action.
“This is about protecting public health,” he said. “We will not allow unsafe, unapproved drugs to be sold in our state.”
The Attorney General’s office continues to monitor clinics and online platforms as part of an ongoing investigation.
Related Topics:
Nikki Tamboli Diet Highlights Home Cooking And Discipline
